88 related articles for article (PubMed ID: 3266842)
41. Tumor-infiltrating lymphocytes: in vitro characterization of morphological and phenotypical changes.
Halpern J; Islam A; Simich JP; Piver MS; Ambrus JL; Bielat KL
Cancer Detect Prev; 1988; 13(1):1-7. PubMed ID: 3265648
[TBL] [Abstract][Full Text] [Related]
42. [Cellular immunity of the patients with malignant glioma -- with special reference to the depressed cell-mediated immunity of the cerebrospinal (author's transl)].
Uemura S; Wada S; Kodama T; Matsukado Y
No Shinkei Geka; 1977 Aug; 5(9):931-9. PubMed ID: 303336
[No Abstract] [Full Text] [Related]
43. Immunomagnetic separation of infiltrating T lymphocytes from brain tumors.
Bosnes V; Hirschberg H
J Neurosurg; 1989 Aug; 71(2):218-23. PubMed ID: 2664096
[TBL] [Abstract][Full Text] [Related]
44. Separation, phenotyping and limiting dilution analysis of T-lymphocytes infiltrating human solid tumors.
Whiteside TL; Miescher S; Hurlimann J; Moretta L; von Fliedner V
Int J Cancer; 1986 Jun; 37(6):803-11. PubMed ID: 3086239
[TBL] [Abstract][Full Text] [Related]
45. Inflammatory infiltrates and natural killer cell presence in human brain tumors.
Stevens A; Klöter I; Roggendorf W
Cancer; 1988 Feb; 61(4):738-43. PubMed ID: 3338036
[TBL] [Abstract][Full Text] [Related]
46. Immunomodulatory role of TIITS in respect to cytotoxic lymphocytes in four grades of human glioma.
Kumar P; Acharya S; Chatterjee S; Kumari A; Chaudhuri S; Singh MK; Ghosh SN; Chaudhuri S
Cell Immunol; 2012; 276(1-2):176-86. PubMed ID: 22704241
[TBL] [Abstract][Full Text] [Related]
47. Some remarks on adherence reactivity of autologous PHA--transformed lymphocytes on human glial tumor cells in vitro.
Kałuza J; Krzyszkowski T
Folia Neuropathol; 1994; 32(1):21-30. PubMed ID: 7922099
[TBL] [Abstract][Full Text] [Related]
48. Immunohistological study of mononuclear cell infiltrate in malignant gliomas.
Rossi ML; Hughes JT; Esiri MM; Coakham HB; Brownell DB
Acta Neuropathol; 1987; 74(3):269-77. PubMed ID: 3314311
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical analysis of tumor-infiltrating lymphocytes and adhesion molecules (ICAM-1, NCAM) in human gliomas.
Yamanaka R; Tanaka R; Saito T
Neurol Med Chir (Tokyo); 1994 Sep; 34(9):583-7. PubMed ID: 7526247
[TBL] [Abstract][Full Text] [Related]
50. Detection of lymphocytes in malignant gliomas by monoclonal antibodies.
Yasuda K; Alderson T; Phillips J; Sikora K
J Neurol Neurosurg Psychiatry; 1983 Aug; 46(8):734-7. PubMed ID: 6193251
[TBL] [Abstract][Full Text] [Related]
51. Characterization of lymphoid cells isolated from human gliomas.
Farmer JP; Antel JP; Freedman M; Cashman NR; Rode H; Villemure JG
J Neurosurg; 1989 Oct; 71(4):528-33. PubMed ID: 2795172
[TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical and in vitro functional analysis of pineal-germinoma infiltrating lymphocytes: report of a case.
Sawamura Y; Hamou MF; Kuppner MC; de Tribolet N
Neurosurgery; 1989 Sep; 25(3):454-7; discussion 457-8. PubMed ID: 2671789
[TBL] [Abstract][Full Text] [Related]
53. Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies.
von Hanwehr RI; Hofman FM; Taylor CR; Apuzzo ML
J Neurosurg; 1984 Jun; 60(6):1138-47. PubMed ID: 6374063
[TBL] [Abstract][Full Text] [Related]
54. Analysis of mixed lymphocyte-tumor culture in patients with malignant brain tumor.
Yoshida S; Tanaka R; Ono M; Takai N; Saito T
J Neurosurg; 1989 Sep; 71(3):398-402. PubMed ID: 2527972
[TBL] [Abstract][Full Text] [Related]
55. Lymphocyte-mediated cytotoxicity against gliomas.
Rainbird S; Allwood G; Ridley A
Brain; 1981 Sep; 104(3):451-64. PubMed ID: 7272710
[TBL] [Abstract][Full Text] [Related]
56. [The role of tumor infiltrating lymphocytes in the immunopathology of gliomas].
Geppert A; Patt S
Neurol Neurochir Pol; 2001; 35(4):661-6. PubMed ID: 11783408
[TBL] [Abstract][Full Text] [Related]
57. [Immunological study in long-term survivals of glioblastoma (author's transl)].
Mineura K; Mori T; Katakura R; Suzuki J
Neurol Med Chir (Tokyo); 1979 Mar; 19(3):239-44. PubMed ID: 86961
[No Abstract] [Full Text] [Related]
58. [Various immunological parameters studied in patients with malignant brain tumor. Correlation between clinical stage and T cell subsets].
Inoue I; Yoshida J; Kato K; Wakabayashi T; Kobayashi T; Kageyama N
Neurol Med Chir (Tokyo); 1985 Mar; 25(3):168-76. PubMed ID: 2409460
[No Abstract] [Full Text] [Related]
59. Suppressor cell activity triggered by tumor associated antigen in patients with intracranial glioma.
Lin SM; Hung CC
Taiwan Yi Xue Hui Za Zhi; 1986 Jan; 85(1):8-18. PubMed ID: 2940327
[No Abstract] [Full Text] [Related]
60. Immunohistochemical analysis of infiltrating lymphocytes in central nervous system tumors.
Paine JT; Handa H; Yamasaki T; Yamashita J; Miyatake S
Neurosurgery; 1986 Jun; 18(6):766-72. PubMed ID: 3488516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
